Ditchcarbon
  • Customers
  1. Organizations
  2. Takeda
Public Profile
Pharmaceutical Preparation Manufacturing
JP
updated 10 days ago

Takeda

Company website

Takeda Pharmaceutical Company Limited, commonly known as Takeda, is a leading global biopharmaceutical firm headquartered in Japan. Founded in 1781, Takeda has evolved into a prominent player in the pharmaceutical industry, with a strong presence in regions such as North America, Europe, and Asia. The company focuses on key therapeutic areas, including oncology, gastroenterology, neuroscience, and rare diseases, offering innovative treatments that address unmet medical needs. Takeda is renowned for its commitment to research and development, with a robust pipeline of biologics and small molecules. Notable achievements include its strategic acquisitions and partnerships that have bolstered its market position, making it one of the largest pharmaceutical companies in the world. With a dedication to patient-centric solutions, Takeda continues to lead in delivering unique therapies that improve health outcomes globally.

DitchCarbon Score

How does Takeda's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

75

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Takeda's score of 75 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.

86%

Let us know if this data was useful to you

Takeda's reported carbon emissions

In 2023, Takeda Pharmaceutical Company reported total greenhouse gas emissions of approximately 4,265,000,000 kg CO2e. This includes Scope 1 emissions of about 279,000,000 kg CO2e, Scope 2 emissions of approximately 33,000,000 kg CO2e (market-based), and a significant contribution from Scope 3 emissions, which totalled around 3,953,000,000 kg CO2e. Takeda has set ambitious climate commitments, aiming to achieve net-zero greenhouse gas emissions for Scopes 1 and 2 by 2035 and for its entire value chain, including Scope 3 emissions, by 2040. The company has also committed to reducing absolute Scope 1 and 2 emissions by 40% by FY2025 from a FY2016 baseline and achieving a 100% reduction by FY2040. Furthermore, Takeda aims for 67% of its suppliers to have science-based targets by 2024. In addition to these near-term targets, Takeda has long-term goals to reduce Scope 1 and 2 emissions by 90% by FY2035 and Scope 3 emissions by 90% by FY2040. These targets align with the Science Based Targets initiative (SBTi) and reflect Takeda's commitment to addressing climate change and reducing its carbon footprint.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201520162017201820192020202120222023
Scope 1
96,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
161,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
Scope 3
226,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Takeda's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Takeda is in JP, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Takeda is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Emmaus Life Sciences, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Astellas

JP
•
Pharmaceutical Preparation Manufacturing
Updated 35 minutes ago

Reata Pharmaceuticals

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

RVL Pharmaceuticals plc

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Cardax, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

FUJIFILM Holdings Corporation

JP
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.8
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy